Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1855 News Items found Hedvig Hricak Named President of Radiological Society Monday, February 1, 2010 Hedvig Hricak, Chair of Memorial Sloan Kettering's Department of Radiology and incumbent of the Carroll and Milton Petrie Chair, has been named the 95th President of the Radiological Society of North America Board of Directors. New Center Uses Mathematical Models to Understand Cancer Monday, February 1, 2010 In October 2009, a team of eight researchers, six of whom are at Memorial Sloan Kettering, received an $11 million, five-year grant from the NCI to form one of 12 Physical Sciences-Oncology Centers (PS-OCs) in the United States. Researchers Link Gene that Causes Parkinson's Disease to Cancer Monday, February 1, 2010 A multidisciplinary team of Memorial Sloan Kettering investigators has shown for the first time that the gene that causes the inherited form of Parkinson's disease also plays a role in many types of cancer, including colon and lung cancers and glioblastoma, the most common form of brain cancer. Samuel Singer Appointed Service Chief Monday, February 1, 2010 Samuel Singer has been appointed Chief of the Gastric and Mixed Tumor Service in the Department of Surgery. Work of Postdoctoral Researchers Spotlighted at Third Annual Symposium Monday, February 1, 2010 Each year since 2007, Memorial Sloan Kettering's postdoctoral researchers have had the opportunity to showcase their research accomplishments at the annual Postdoctoral Research Symposium. An Interview With Simon Powell Tuesday, December 1, 2009 Dr. Powell joined Memorial Sloan Kettering in 2008 as Chair of the Department of Radiation Oncology with a joint appointment in Sloan Kettering Institute's Molecular Biology Program. FDA Approves Lymphoma Drug Developed at Memorial Sloan Kettering Tuesday, December 1, 2009 Patients with a rare but aggressive form of cancer now have access to a drug that has proven effective after the disease becomes resistant to standard treatments. Researchers Design More Effective Cancer Vaccine Tuesday, December 1, 2009 Memorial Sloan Kettering investigators have shown that a new type of cancer vaccine might be more effective than previous therapies at inducing immune cells to destroy tumors. Experimental Breast Cancer Drug Shows Promise in Aggressive Form of Disease Thursday, October 1, 2009 Results from studies in cell cultures and mouse models suggest that the experimental targeted therapy PU-H71 may be effective against one of the most aggressive forms of breast cancer. Linking Histones and Cancer Thursday, October 1, 2009 Structural biologists at Memorial Sloan Kettering Cancer Center are collaborating with biochemists and cell biologists at The Rockefeller University to study how cells read genetic instructions imprinted on histones, DNA's packaging proteins. Pagination First page « First Previous page ‹ Previous … Page 178 Page 179 Page 180 Page 181 Current page 182 Page 183 Page 184 Page 185 Page 186 Next page Next › Last page Last » Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment